{'fraction_non_alphanumeric': 0.015102481121898598, 'fraction_numerical': 0.0, 'mean_word_length': 5.581560283687943, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Medical treatment for hydatid disease?

The management of soft-tissue sarcomas requires particular skill by pathologists, surgeons, radiotherapists, and chemotherapists if optimal treatment is to be given. Ideally, all patients with these tumours should be treated in specialist oncology centres and whenever possible should be included in prospective randomised studies. While the evidence from the present series using historical controls is too preliminary to justify radical changes in managing these tumours, these results have warranted setting up prospective randomised trials. In time these should lead to standardisation of the treatment of patients presenting with localised disease. New drugs and combinations need continued testing in patients with advanced disease. These detailed studies of all stages of a rare tumour can be carried out effectively only by the co-operation of large centres in several countries.